Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Lymphomatoid papulosis
ADR ID BADD_A08270
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.03      Epidermal and dermal conditions
23.03.08      Papulosquamous conditions
23.03.08.011      Lymphomatoid papulosis
Description Clinically benign, histologically malignant, recurrent cutaneous T-cell lymphoproliferative disorder characterized by an infiltration of large atypical cells surrounded by inflammatory cells. The atypical cells resemble REED-STERNBERG CELLS of HODGKIN DISEASE or the malignant cells of CUTANEOUS T-CELL LYMPHOMA. In some cases, lymphomatoid papulosis progresses to lymphomatous conditions including MYCOSIS FUNGOIDES; HODGKIN DISEASE; CUTANEOUS T-CELL LYMPHOMA; or ANAPLASTIC LARGE-CELL LYMPHOMA. [MeSH]
MedDRA Code 10056670
MeSH ID D017731
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Lymphomatoid papulosis | Lymphomatoid Papulosis | Lymphomatoid Papuloses | Papuloses, Lymphomatoid | Papulosis, Lymphomatoid
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00121Amlodipine0.000006%
BADD_D00680Dimethyl fumarate0.001080%
BADD_D01275Levofloxacin0.000127%
BADD_D01300Lisinopril0.000025%
BADD_D01449Metronidazole0.000066%
BADD_D02010Sertraline0.000028%
BADD_D02028Sirolimus0.000134%
BADD_D02464Fingolimod0.001133%
The 1th Page    1    Total 1 Pages